HealthPlans4All FamilyFamilyFamily
 
Home  |  Tips  |  Resources  |  News  |  Free Quote 
 
   

 

Resources :: Womens Health :: Cervical Dysplasia Resource Index

Resources
Home
Womens Health
Adenomyosis
AIDS HIV
Breast Augmentation
Breast Cancer
Breast Reduction
Breasts
Cervical Dysplasia
Colposcopy
Endometriosis
Female Pattern Hair Loss
Gynecologic Cancers
Hysterectomy
Kegel Exercises
Mammogram
Menopause
Menorrhagia
Menstruation
Morning Sickness
Obstetrics And Gynecology
Organizations
Osteoporosis
Ovarian Cysts
Pap Smear Test
Pregnancy And Birth
Products And Services
Reproductive Health
Uterine Fibroids
Home >> Womens Health >> Cervical Dysplasia
Womens Health :: Cervical Dysplasia Links
There are currently no links for Cervical Dysplasia. To add a link select "Submit A Link" from the menu.
  Search Links    
Links Home ] [ Submit A Link ]
Womens Health :: Cervical Dysplasia News
Edimer Pharmaceuticals, CMC Biologics enter contract to develop EDI200 recombinant protein
 Thu, 09 Sep 2010 22:07:12 -0700 -- Edimer Pharmaceuticals and CMC Biologics today announce the execution of a manufacturing contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe.
Fitness calendar
 Tue, 07 Sep 2010 07:19:06 -0700 -- RedCross
Ob-Gyns Recommend HPV Vaccination For Young Girls
 Tue, 24 Aug 2010 06:33:39 -0700 -- Girls ages 11 to 12 should receive either of the two FDA-approved vaccines to prevent cervical cancer, ideally before they become sexually active, according to The American College of Obstetricians and Gynecologists. In its recommendations issued today, The College emphasizes that routine Pap screening is still necessary for all women beginning at age 21, including those who have had the ...
Advaxis Completes Dosing Vanguard Group In Phase II Cervical Dysplasia (CIN) Study
 Fri, 20 Aug 2010 04:34:19 -0700 -- Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study. As per the FDA approved design for this trial, an initial group of 3 patients in each dosing group is to be treated and ...


 


cornerleftdown cornerrightdown